Intra-sheath vs Extra-sheath Injection for De Quervain's Tenosynovitis
NCT: NCT04895956 · RECRUITING
Brief Summary
The aim of the study is to determine whether or not extra-sheath steroid injections are inferior to intra-sheath steroid injections in the treatment of DeQuervain's Tenosynovitis. Patients will be randomized to either the intra-sheath group or the extra-sheath group and their pre-injection level of pain will be assessed using the visual analog scale. Appropriate injections will then be administered by 1 of 3 UC Davis hand surgeons. Six weeks post injection the patients will be reassessed using the visual analog scale and their score at 6 weeks will be compared to their pre-injection score.
Frequently Asked Questions
What is Intra-sheath vs Extra-sheath Injection for De Quervain's Tenosynovitis?
Intra-sheath vs Extra-sheath Injection for De Quervain's Tenosynovitis is a clinical trial registered under NCT04895956. Current status: RECRUITING.
What is the status of NCT04895956?
The current status of NCT04895956 (Intra-sheath vs Extra-sheath Injection for De Quervain's Tenosynovitis) is: RECRUITING.
When did Intra-sheath vs Extra-sheath Injection for De Quervain's Tenosynovitis start?
Intra-sheath vs Extra-sheath Injection for De Quervain's Tenosynovitis started on 2022-01-24.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.